Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08RSU
|
||||
Former ID |
DIB018280
|
||||
Drug Name |
[3H]DPCPX
|
||||
Synonyms |
[3H]-DPCPX
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [540656] | ||
Structure |
Download2D MOL |
||||
Formula |
C16H24N4O2
|
||||
InChI |
InChI=1S/C16H24N4O2/c1-3-9-19-14-12(15(21)20(10-4-2)16(19)22)17-13(18-14)11-7-5-6-8-11/h11H,3-10H2,1-2H3,(H,17,18)/i1T,2T,9T,10T
|
||||
InChIKey |
FFBDFADSZUINTG-LEZITTIZSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A2b receptor | Target Info | Antagonist | [527107] | |
Adenosine A1 receptor | Target Info | Antagonist | [526188] | ||
Pathway Interaction Database | C-MYB transcription factor network | ||||
References | |||||
Ref 526188 | Inhibition of human mast cell activation with the novel selective adenosine A(2B) receptor antagonist 3-isobutyl-8-pyrrolidinoxanthine (IPDX)(2). Biochem Pharmacol. 2001 Nov 1;62(9):1163-73. | ||||
Ref 527107 | [3H]OSIP339391, a selective, novel, and high affinity antagonist radioligand for adenosine A2B receptors. Biochem Pharmacol. 2004 Jul 15;68(2):305-12. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.